Compare Carnival Corp (CCL) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Carnival Corp vs Novartis AG — how do they compare? Carnival Corp trades at $26.47 (market cap $36.45B), while Novartis AG trades at $152.91 (market cap $293.74B). The key difference: Novartis AG is far larger — about 8.1× Carnival Corp's market cap, and Novartis AG pays the higher dividend (3.09%). Which is the better fit depends on your goals.
| CCL | NVS | |
|---|---|---|
Market Cap | $36.45B | $293.74B |
Sector | Consumer Cyclical | Health |
52-Week High | $33.99 | $168.62 |
52-Week Low | $23.89 | $113.50 |
Enterprise Value | $60.37B | $333.76B |
Dividend Yield | 1.69% | 3.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Carnival Corp
Carnival is the largest global cruise company, with 91 ships in its fleet in October 2022, with eight of its nine brands set to be fully redeployed by the end of 2022. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America.
Read more on CCL →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
